A Nationwide Survey of Parkinson's Disease Medicines Availability and Affordability in Nigeria
Njideka Okubadejo(University of Lagos), Olajumoke Oshinaike(Lagos State University), Olugbo Y. Obiabo(Delta State University), Oluwadamilola O. Ojo(University of Lagos), Osigwe Agabi(University of Lagos), Ernest Nwazor(National Institutes of Health), Sani Abubakar(Ahmadu Bello University), Fatai Kunle Salawu(Federal Medical Centre), Kolawole Wahab(University of Ilorin Teaching Hospital)
Cited by 32
Related Papers
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial
|The Lancet|2023|385
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
|Neurology|2021|155
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study
|The Lancet Neurology|2023|154
Health Related Quality of Life of Stroke Survivors: Experience of a Stroke Unit
|International Journal of Biomedical Science|2012|122